Evidence map›Paper›PMID 18391202›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2008

Unregulated smooth-muscle myosin in human intestinal neoplasia.

Pia Alhopuro, Denis Phichith, Sari Tuupanen, Heli Sammalkorpi, Miranda Nybondas, Juha Saharinen, James P Robinson, Zhaohui Yang, Li-Qiong Chen, Torben Orntoft and 14 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 86 citations in OpenAlex.

  1. Article
  2. Article
  3. Oncology research · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Role of non-coding variants in cardiovascular disease.Journal of cellular and molecular medicine · 2023
    Review
  8. Article
  9. Identification of hub genes and pathways in bladder cancer using bioinformatics analysis.American journal of clinical and experimental urology · 2022
    Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 13 institutions in 6 countries.

Pia AlhopuroDepartment of Medical Genetics and Division of Pathology, HUSLAB and Haartman Institute, Helsinki University Central Hospital and Genome Scale Biology Program, Biomedicum Helsinki, University of Helsinki, 00014, Helsinki, Finland.
Denis Phichith
Sari Tuupanen
Heli Sammalkorpi
Miranda Nybondas
Juha Saharinen
James P Robinson
Zhaohui Yang
Li-Qiong Chen
Torben Orntoft
Jukka-Pekka Mecklin
Heikki Järvinen
Charis Eng
Gabriela Moeslein
Darryl Shibata
Richard S Houlston
Anneke Lucassen
Ian P M Tomlinson
Virpi Launonen
Ari Ristimäki
Diego Arango
Auli Karhu
H Lee Sweeney
Lauri A Aaltonen
University of Helsinki · FIUniversity of Pennsylvania · USAarhus University Hospital · DKCancer Research UK · GBCase Western Reserve University · USCentral Finland Health Care District · FICIBBIM-Nanomedicine · ESHelios Universitätsklinikum Wuppertal · DEHelsinki University Hospital · FIInstitute of Cancer Research · GBPrincess Anne Hospital · GBQueen Mary University of London · GBUniversity of Southern California · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A recent study described a recessive ATPase activating germ-line mutation in smooth-muscle myosin (smmhc/myh11) underlying the zebrafish meltdown (mlt) phenotype. The mlt zebrafish develops intestinal abnormalities reminiscent of human Peutz-Jeghers syndrome (PJS) and juvenile polyposis (JP). To examine the role of MYH11 in human intestinal neoplasia, we searched for MYH11 mutations in patients with colorectal cancer (CRC), PJS and JP. We found somatic protein-elongating frameshift mutations in 55% of CRCs displaying microsatellite instability and in the germ-line of one individual with PJS. Additionally, two somatic missense mutations were found in one microsatellite stable CRC. These two missense mutations, R501L and K1044N, and the frameshift mutations were functionally evaluated. All mutations resulted in unregulated molecules displaying constitutive motor activity, similar to the mutant myosin underlying mlt. Thus, MYH11 mutations appear to contribute also to human intestinal neoplasia. Unregulated MYH11 may affect the cellular energy balance or disturb cell lineage decisions in tumor progenitor cells. These data challenge our view on MYH11 as a passive differentiation marker functioning in muscle contraction and add to our understanding of intestinal neoplasia.

Indexed as

Gene Expression Regulation, NeoplasticMutationAdenomatous Polyposis ColiAmino Acid SequenceCase-Control StudiesColorectal NeoplasmsDNA Mutational AnalysisHumansIntestinal NeoplasmsMolecular Sequence DataMyosin Heavy ChainsMyosin Type IIPeutz-Jeghers SyndromeSmooth Muscle MyosinsMYH11 protein, humanMyosin Heavy ChainsMyosin Type IISmooth Muscle Myosins

Identifiers

PMID18391202
PMCPMC2291082
OpenAlexW2007381839

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.